Stephens Inc. AR Decreases Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

Stephens Inc. AR decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,865 shares of the medical research company’s stock after selling 123 shares during the quarter. Stephens Inc. AR’s holdings in Thermo Fisher Scientific were worth $3,484,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Cohen Lawrence B raised its position in Thermo Fisher Scientific by 2.0% in the 2nd quarter. Cohen Lawrence B now owns 10,185 shares of the medical research company’s stock worth $2,991,000 after buying an additional 195 shares during the last quarter. Private Trust Co. NA increased its position in shares of Thermo Fisher Scientific by 66.7% during the 2nd quarter. Private Trust Co. NA now owns 3,273 shares of the medical research company’s stock valued at $961,000 after purchasing an additional 1,310 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. Parallel Advisors LLC now owns 9,416 shares of the medical research company’s stock valued at $2,578,000 after purchasing an additional 393 shares during the last quarter. Barrett Asset Management LLC increased its position in shares of Thermo Fisher Scientific by 0.4% during the 1st quarter. Barrett Asset Management LLC now owns 111,500 shares of the medical research company’s stock valued at $30,520,000 after purchasing an additional 395 shares during the last quarter. Finally, Gateway Investment Advisers LLC increased its position in shares of Thermo Fisher Scientific by 45.5% during the 2nd quarter. Gateway Investment Advisers LLC now owns 38,146 shares of the medical research company’s stock valued at $11,203,000 after purchasing an additional 11,928 shares during the last quarter. 88.21% of the stock is owned by institutional investors and hedge funds.

In related news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $268.29, for a total value of $670,725.00. Following the completion of the sale, the chief financial officer now directly owns 40,029 shares of the company’s stock, valued at approximately $10,739,380.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $284.83, for a total value of $14,241,500.00. Following the completion of the transaction, the chief executive officer now owns 342,193 shares of the company’s stock, valued at $97,466,832.19. The disclosure for this sale can be found here. Insiders sold a total of 52,775 shares of company stock valued at $14,986,676 over the last three months. 0.45% of the stock is currently owned by insiders.

Thermo Fisher Scientific stock traded up $2.84 during midday trading on Friday, hitting $276.15. The stock had a trading volume of 992,900 shares, compared to its average volume of 1,599,691. The firm’s fifty day moving average is $286.98 and its two-hundred day moving average is $272.14. The company has a market capitalization of $107.92 billion, a PE ratio of 22.99, a P/E/G ratio of 1.76 and a beta of 1.11. Thermo Fisher Scientific Inc. has a 52-week low of $208.34 and a 52-week high of $305.45. The company has a current ratio of 1.49, a quick ratio of 1.07 and a debt-to-equity ratio of 0.58.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.01 by $0.03. The company had revenue of $6.32 billion during the quarter, compared to analyst estimates of $6.31 billion. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.75 EPS. As a group, equities research analysts predict that Thermo Fisher Scientific Inc. will post 12.24 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s dividend payout ratio is 6.83%.

Several equities research analysts have recently commented on TMO shares. Credit Suisse Group reaffirmed a “buy” rating and set a $310.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. BTIG Research upped their price target on shares of Thermo Fisher Scientific to $320.00 and gave the company a “buy” rating in a research report on Thursday, May 23rd. Argus upped their price target on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Needham & Company LLC upped their price target on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the company a “buy” rating in a research report on Thursday, July 25th. Finally, Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price target for the company in a research report on Wednesday, June 12th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Thermo Fisher Scientific has a consensus rating of “Buy” and an average price target of $303.17.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Recommended Story: Google Finance Portfolio

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.